Exenatide (EXE) is the synthetic analog of exendin-4, a GLP-1 homologous originally purified from the salivary glands of the lizard Heloderma suspectum, and it is currently employed in the treatment of type 2 diabetes (T2D) [3, 4]. Here, GLP1R is linked to type 2 diabetes mellitus.